绿新生物科技(01084)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01084 绿新生物科技

未开盘 08-20 16:09:07

0.630

-0.010

-1.56%

最高0.650	最低0.605	成交量42.20万
今开0.620	昨收0.640	日振幅7.03%
总市值5.51亿	流通市值5.51亿	总股本8.74亿
成交额26.39万	换手率0.05%	流通股本8.74亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01084","market":"HK","secType":"STK","nameCN":"绿新生物科技","latestPrice":0.63,"timestamp":1787213347630,"preClose":0.64,"halted":0,"volume":422000,"delay":0,"changeRate":-0.015625000000000014,"floatShares":874000000,"shares":874000000,"eps":0.008902374938224149,"marketStatus":"未开盘","change":-0.01,"latestTime":"08-20 16:09:07","open":0.62,"high":0.65,"low":0.605,"amount":263940,"amplitude":0.070313,"askPrice":0.63,"askSize":4000,"bidPrice":0.625,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":0.009735441216846961,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787275800000},"marketStatusCode":0,"adr":0,"listingDate":1571241600000,"exchange":"SEHK","adjPreClose":0.64,"dividendRate":0.019048,"openAndCloseTimeList":[[1787189400000,1787198400000],[1787202000000,1787212800000]],"volumeRatio":2.9971590885675603,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01084","defaultTab":"news","newsList":[{"id":"1124661890","title":"绿新生物科技（01084）拟于8月31日召开董事会审议中期业绩及中期股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1124661890","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124661890?lang=zh_cn&edition=full","pubTime":"2026-08-19 18:06","pubTimestamp":1787133996,"startTime":"0","endTime":"0","summary":"绿新生物科技（01084）公告称，公司董事会已安排于2026年8月31日（星期一）召开会议，主要议程包括：一、审核及批准公司及其附属公司截至2026年6月30日止六个月的未经过审计的中期业绩；二、考虑宣派中期股息（如有）。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658972378","title":"绿新生物科技中期预亏收窄 卡拉胶销量提升带动经营现金流入增超7倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2658972378","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658972378?lang=zh_cn&edition=full","pubTime":"2026-08-12 19:53","pubTimestamp":1786535580,"startTime":"0","endTime":"0","summary":"8月12日，绿新生物科技（01084）发布公告，预计截至2026年6月30日的六个月内，公司预计录得本公司拥有人的应占亏损净额介乎约100万元至400万元，而2025年同期，本公司拥有人的应占亏损净额为1207万元。这表明公司的表现有所改善，主要是由于卡拉胶产品销量因公司具竞争优势的定价策略而增加，推动了报告期间的收益及毛利增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608123839353164.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608123839353164.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","BK1129","159399","BK4585","01084","SPHQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658797659","title":"绿新生物科技(01084)发盈警 预期中期股东应占亏损净额同比收窄至约100万元至400万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658797659","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658797659?lang=zh_cn&edition=full","pubTime":"2026-08-12 18:52","pubTimestamp":1786531966,"startTime":"0","endTime":"0","summary":"智通财经APP讯，绿新生物科技(01084)发布公告，经初步审阅现有可得资料(包括但不限于本集团截至2026年6月30日止6个月(报告期间)的未经审核综合管理账目)后，董事会谨此通知本公司股东(股东)及有意投资者，于报告期间，本公司预期取得本公司拥有人应占亏损净额介乎约人民币100万元至人民币400万元，而截至2025年6月30日止6个月的本公司拥有人应占亏损净额为人民币1207万元。本集团的表现有所改善，主要是由于卡拉胶产品销量因本集团具竞争优势的定价策略而增加，推动报告期间的收益及毛利增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1479075.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01084","BK1129"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126444103","title":"绿新生物科技：卡拉胶产品销量攀升，中期业绩预期向好","url":"https://stock-news.laohu8.com/highlight/detail?id=1126444103","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126444103?lang=zh_cn&edition=full","pubTime":"2026-08-12 18:51","pubTimestamp":1786531895,"startTime":"0","endTime":"0","summary":"绿新生物科技的业绩正迎来强劲推动力——主要源于其卡拉胶产品销量的显著增长，预期中期业绩将因此录得亮眼表现。随着市场对卡拉胶需求的持续升温，该公司核心产品的销售规模不断扩大。从业务结构来看，卡拉胶作为绿新生物科技的关键产品线，其市场表现往往能左右公司整体业绩走势。观察人士认为，若销量增长势头得以延续，绿新生物科技的中期业绩不仅将超出市场预期，更可能为后续的年度盈利奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1129","01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114128735","title":"绿新生物科技(01084)预计2026上半年亏损收窄至1至4百万元 经营现金流入同比增逾7倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1114128735","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114128735?lang=zh_cn&edition=full","pubTime":"2026-08-12 18:51","pubTimestamp":1786531890,"startTime":"0","endTime":"0","summary":"绿新生物科技有限公司8月12日公告，根据对现有资料的初步审阅，公司预计截至2026年6月30日止六个月归属公司拥有人应占亏损净额介乎人民币1百万元至人民币4百万元，较2025年同期的亏损人民币12.07百万元大幅收窄。受益于具有竞争力的定价策略，报告期间销售收入及毛利均实现增长。报告期内，集团经营现金流入净额较2025年同期增长逾7倍。公司计划于2026年8月底之前发布完整的中期业绩公告。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167617759","title":"绿新生物科技预期2026年上半年净亏损100万至400万元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=1167617759","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167617759?lang=zh_cn&edition=full","pubTime":"2026-08-12 18:51","pubTimestamp":1786531870,"startTime":"0","endTime":"0","summary":"绿新生物科技（GREEN FRESH BIO）发布业绩预告，预计截至2026年6月30日的六个月期间，将录得归属于公司股东的净亏损。这一数字大致锁定在100万元人民币至400万元人民币的区间之内。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1129","01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119189414","title":"绿新生物科技更新2026年7月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1119189414","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119189414?lang=zh_cn&edition=full","pubTime":"2026-08-03 12:02","pubTimestamp":1785729738,"startTime":"0","endTime":"0","summary":"绿新生物科技有限公司于2026年8月3日发布截至2026年7月31日的证券变动月报表。公告显示，公司报告期内已发行股本及库藏股数量保持不变，股本结构维持稳定。报告期内，绿新生物科技普通股注册股本总额为50,000,000,000股，面值为每股港币0.01元，注册股本合计仍为港币500,000,000元，与上月保持一致。公告显示，绿新生物科技在2026年7月期间没有新增发行、购回、注销或库藏股变动。公司在公告中确认，目前已符合香港联交所关于公众持股量的相关规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100738946","title":"绿新生物科技（01084）旗下环保三文治盒获香港环保署列入“绿色餐具平台”","url":"https://stock-news.laohu8.com/highlight/detail?id=1100738946","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100738946?lang=zh_cn&edition=full","pubTime":"2026-07-08 20:15","pubTimestamp":1783512941,"startTime":"0","endTime":"0","summary":"2026年7月8日，绿新生物科技有限公司公布，其全资附属公司格林（中国）科技发展有限公司代理的BOTEC品牌环保透明窗口三文治盒已获香港环境保护署批准，列入“绿色餐具平台”。董事会表示，产品成功进入“绿色餐具平台”将有助于提升集团品牌在香港及国际市场的知名度与竞争力，并对业务发展产生积极影响。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649955059","title":"绿新生物科技(01084)：旗下BOTEC品牌环保透明窗口三文治盒通过审批成为香港环保署绿色餐具平台列表产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2649955059","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649955059?lang=zh_cn&edition=full","pubTime":"2026-07-08 20:14","pubTimestamp":1783512850,"startTime":"0","endTime":"0","summary":"董事会认为，是次获纳入绿色餐具平台，不仅代表集团的BOTEC品牌环保三文治盒在环保标准上获得充分的认可，更是集团在推动可持续发展及绿色科技产品发展上的一个重要里程碑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464902.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1129","01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162936371","title":"绿新生物科技6月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1162936371","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162936371?lang=zh_cn&edition=full","pubTime":"2026-07-02 16:30","pubTimestamp":1782981056,"startTime":"0","endTime":"0","summary":"绿新生物科技有限公司于2026年7月2日发布截至2026年6月30日的证券变动月报表。公告显示，公司本月内并无新增发行、购回或注销股份活动，整体股本结构保持稳定。已发行股份数目截至6月底仍为874,120,000股，库藏股数目为0，已发行股份总数与上月底一致。公司确认已满足香港联交所相关的公众持股量要求。据公告，6月份并无股份期权、权证、可换股票据及其他协议或安排导致的股份变动，亦未发生任何股份购回或注销。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186061522","title":"绿新生物科技2026年5月股份变动月报表：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1186061522","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186061522?lang=zh_cn&edition=full","pubTime":"2026-06-02 15:36","pubTimestamp":1780385779,"startTime":"0","endTime":"0","summary":"绿新生物科技有限公司（股票代码：01084）于2026年6月2日发布截至2026年5月31日的股份变动月报表，报告期内公司注册股本维持在500,000,000港元，总面值为每股0.01港元，相当于50,000,000,000股注册股份数量。\n公司已发行普通股数量在5月末为874,120,000股，与上月底持平，期内无新增发行、购回、注销或库藏股活动。公司确认已满足香港联合交易所有限公司相关上市规则要求，并将继续遵循适用法律法规开展业务。\n上述公告由公司秘书苏智文签署并对外公布。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138454302","title":"绿新生物科技2026年4月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1138454302","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138454302?lang=zh_cn&edition=full","pubTime":"2026-05-04 11:52","pubTimestamp":1777866726,"startTime":"0","endTime":"0","summary":"2026年5月4日，绿新生物科技（股票代码：01084）发布2026年4月股份变动月报。公告显示，截至2026年4月30日，绿新生物科技已发行股份总数为874,120,000股，与上月保持一致，未进行任何新增发行、购回或注销活动。\n报告显示，公司普通股注册股本维持50,000,000,000股，股份面值为每股0.01港元，总注册股本折合约5.00亿港元。截至报告期末，绿新生物科技并无库存股份，已发行股份总数与此前保持不变，公司确认已符合适用的公众持股量要求。\n公告称，公司所有证券发行为董事会正式批准并遵守香港联交所《上市规则》及其他适用法律法规。公告由公司秘书苏智文签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106679232","title":"绿新生物科技授予董事股份购回授权，规模达已发行股本一成","url":"https://stock-news.laohu8.com/highlight/detail?id=1106679232","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106679232?lang=zh_cn&edition=full","pubTime":"2026-04-24 21:26","pubTimestamp":1777037175,"startTime":"0","endTime":"0","summary":"绿新生物科技于最新公告中披露，董事会拟在公司股东年度大会上寻求授权，回购最多相当于已发行股本10%的股份。董事会认为，适度回购可增强每股资产净值及每股盈利水平，符合公司及股东的整体利益。该公司强调，若获授回购授权，董事会将根据市况及财务状况酌情决定回购时机与价格。董事会表示，此次措施旨在强化公司资本结构，以实现长期价值提升与股东利益保护。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"绿新生物科技授予董事股份购回授权，规模达已发行股本一成","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160850559","title":"绿新生物科技2025年营收下滑聚焦海藻与生物降解多元化布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1160850559","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160850559?lang=zh_cn&edition=full","pubTime":"2026-04-24 21:24","pubTimestamp":1777037075,"startTime":"0","endTime":"0","summary":"绿新生物科技于2025财年录得收益人民币904.7百万元，同比下降8.6%；毛利为人民币167.2百万元，毛利率降至18.5%。年内溢利人民币5.4百万元，较上一财年的人民币60.9百万元大幅减少，反映宏观经济和海外市场需求放缓对整体业绩造成压力。截至2025年12月31日，集团总资产达人民币1,632.3百万元，负债总额为人民币785.2百万元，净资产约人民币847.1百万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"绿新生物科技2025年营收下滑聚焦海藻与生物降解多元化布局","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110572544","title":"绿新生物科技3月股份变动月报，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1110572544","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110572544?lang=zh_cn&edition=full","pubTime":"2026-04-02 12:42","pubTimestamp":1775104924,"startTime":"0","endTime":"0","summary":"绿新生物科技有限公司（股票代码：01084）于2026年4月2日发布了截至2026年3月31日的股份变动月报。报告显示，公司于本月未进行新增发行或购回注销，股本结构保持不变。\n公司法定注册股本为50,000,000,000股，面值每股0.01港元，法定注册股本总额为500,000,000港元。报告期内，上月底及本月底的已发行股份数均为874,120,000股，无库藏股，未发生任何股份变动。\n公司声明已遵守香港联交所《上市规则》及相关法律法规，所有披露信息均经董事会正式授权批准。本次公告由公司秘书苏智文签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623532830","title":"绿新生物科技(01084)发布年度业绩 股东应占溢利658.8万元 同比减少89.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623532830","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2623532830?lang=zh_cn&edition=full","pubTime":"2026-03-31 01:29","pubTimestamp":1774891787,"startTime":"0","endTime":"0","summary":"智通财经APP讯，绿新生物科技(01084)发布截至2025年12月31日止年度全年业绩，集团收益人民币9.05亿元，同比减少8.55%;股东应占溢利658.8万元，同比减少89.4%;每股盈利0.008元;末期息1.2港仙。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422495.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"绿新生物科技(01084)发布年度业绩 股东应占溢利658.8万元 同比减少89.4%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01084","BK1129"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197447396","title":"绿新生物科技将于2026年07月15日派发末期股息每股0.012港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1197447396","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197447396?lang=zh_cn&edition=full","pubTime":"2026-03-30 23:02","pubTimestamp":1774882952,"startTime":"0","endTime":"0","summary":"绿新生物科技(01084)公告显示，该公司董事会宣布截至2025年12月31日止年度的末期股息为每股0.012港元，派息方案尚待股东于2026年06月12日批准。根据公告，除净日为2026年06月16日，股东如欲享有此次股息权利，须于2026年06月17日16时30分前提交过户文件。公司将于2026年06月18日至06月23日暂停办理股份过户登记，并于2026年06月23日确定股权登记日。该股息预计于2026年07月15日派发。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620429632","title":"绿新生物科技(01084.HK)拟3月30日举行董事会会议审批全年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2620429632","media":"中金财经","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2620429632?lang=zh_cn&edition=full","pubTime":"2026-03-17 19:17","pubTimestamp":1773746222,"startTime":"0","endTime":"0","summary":"格隆汇3月17日丨绿新生物科技(01084.HK)宣布，公司将于2026年3月30日(星期一)举行董事会会议，藉以(其中包括)批准刊发公司及其附属公司截至2025年12月31日止年度的全年业绩，并考虑派发末期股息(如有)的推荐建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260317/32075422.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["01084","BK1129"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144757964","title":"绿新生物科技2025财年营收下滑，经调整净利润0.08亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1144757964","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144757964?lang=zh_cn&edition=full","pubTime":"2026-03-06 19:21","pubTimestamp":1772796100,"startTime":"0","endTime":"0","summary":"绿新生物科技发布公告显示，截至2025年12月31日，公司营收同比出现下滑，经调整净利润预计不超过0.08亿元人民币，而2024财年同期经调整净利润约为0.622亿元人民币。公告指出，净利润出现明显下跌主要源于公司主要亲水胶体产品价格与销量下降，导致收益及毛利减少。根据公司初步测算，管理层预计2025财年经调整净利润与去年同期相比降幅显著。根据公告，完整的2025财年业绩将在2026年3月底前对外披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617844236","title":"绿新生物科技(01084)发盈警 预计年度股东应占净利润不超过800万元 同比减少","url":"https://stock-news.laohu8.com/highlight/detail?id=2617844236","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2617844236?lang=zh_cn&edition=full","pubTime":"2026-03-06 19:18","pubTimestamp":1772795907,"startTime":"0","endTime":"0","summary":"智通财经APP讯，绿新生物科技(01084)发布公告，于2025年财政年度，本公司预期录得本公司拥有人应占净利润不超过人民币800万元，而截至2024年12月31日止年度的本公司拥有人应占净利润约为人民币6220万元。本集团的净利润转差主要由于本集团主要亲水胶体产品类别的价格及销量下降，导致2025年财政年度的收益及毛利减少。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411110.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"绿新生物科技(01084)发盈警 预计年度股东应占净利润不超过800万元 同比减少","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01084"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.greenfreshfood.com","stockEarnings":[{"period":"1week","weight":-0.1},{"period":"1month","weight":-0.1},{"period":"3month","weight":-0.0278},{"period":"6month","weight":0.0016},{"period":"1year","weight":-0.0141},{"period":"ytd","weight":-0.0278}],"compareEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":0.0225},{"period":"3month","weight":0.0036},{"period":"6month","weight":-0.0271},{"period":"1year","weight":0.0212},{"period":"ytd","weight":0.0027}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"绿新生物科技有限公司是一家主要从事生产海藻及植物性亲水胶体产品的投资控股公司。该公司主要通过五大分部运营业务。琼脂销售分部主要从事应用于果冻等琼脂产品的制造及销售。卡拉胶制造及销售分部主要从事应用于糖果零食类卡拉胶产品的制造及销售。魔芋产品制造及销售分部主要从事应用于魔芋产品的制造及销售。复配产品制造及销售分部主要从事应用于肉制品等复配产品的制造及销售。其他分部主要从事奶粉销售等。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.008702},{"month":2,"riseRate":0.571429,"avgChangeRate":-0.066063},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.011272},{"month":4,"riseRate":0.714286,"avgChangeRate":0.096795},{"month":5,"riseRate":0.571429,"avgChangeRate":0.104435},{"month":6,"riseRate":0.571429,"avgChangeRate":0.009845},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.041188},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.024694},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.044595},{"month":10,"riseRate":0.333333,"avgChangeRate":0.040353},{"month":11,"riseRate":0.142857,"avgChangeRate":-0.044514},{"month":12,"riseRate":0.714286,"avgChangeRate":0.033133}],"exchange":"SEHK","name":"绿新生物科技","nameEN":"GREEN FRESH BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"绿新生物科技(01084)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供绿新生物科技(01084)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"绿新生物科技,01084,绿新生物科技股票,绿新生物科技股票老虎,绿新生物科技股票老虎国际,绿新生物科技行情,绿新生物科技股票行情,绿新生物科技股价,绿新生物科技股市,绿新生物科技股票价格,绿新生物科技股票交易,绿新生物科技股票购买,绿新生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"绿新生物科技(01084)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供绿新生物科技(01084)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}